Navigation Links
Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013
Date:4/25/2013

SAN DIEGO, April 25, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced that it will release its first quarter ended March 31, 2013 financial results on Thursday, May 2, 2013.

Cadence management will host a conference call and live webcast to discuss the financial results on Thursday, May 2, 2013 at 1:30pm Pacific Time (4:30pm Eastern Time). Interested investors may participate in the conference call by dialing (877) 303-9145 (domestic) or (760) 536-5203 (international).  To access the webcast, please visit the company's website at www.cadencepharm.com and go to the Investor Relations page.  A replay of the webcast will be available approximately two hours after the call and remain available on the company's website until the next quarterly financial results call.

About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting.  The current version of Cadence Pharmaceuticals' corporate overview may be viewed on the "Investors" page of www.cadencepharm.com, under "Events and Presentations."  Contacts:William R. LaRueSVP & Chief Financial OfficerCadence Pharmaceuticals, Inc.858-436-1400


'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
2. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results
3. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Full Year 2012 Financial Results On March 7, 2013
4. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013
5. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Leerink Swann Global Healthcare Conference In New York City On February 13, 2013
6. Cadence Pharmaceuticals Estimates Fourth Quarter 2012 Net Product Revenue and Provides Full Year 2013 Revenue Guidance
7. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
8. Cadence Pharmaceuticals to Host Analyst and Investor Day
9. Cadence to Open Finished Medical Device Facility
10. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Piper Jaffray 24th Annual Healthcare Conference In New York City On November 28, 2012
11. Cadence Pharmaceuticals Reports Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... , Sept. 7, 2017  Eli Lilly ... announced actions to streamline operations to more efficiently ... improve its cost structure. Global workforce reductions, including ... are expected to impact approximately 3,500 positions. ... company expects annualized savings of approximately $500 million ...
(Date:9/7/2017)... , Sept. 7, 2017   BioLife Solutions , Inc. ... marketer of proprietary clinical grade cell and tissue hypothermic ... that Mike Rice , President and CEO, will be ... Rodman & Renshaw 19 th Annual Global ... time (12:25 p.m. Pacific time). The conference is being held ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly and ... will present new data for galcanezumab and lasmiditan, two ... the International Headache Society (IHC) taking place Sept. 7-10 ... Lilly will highlight new, long-term data from an open-label ... of galcanezumab (120 mg and 240 mg) for the ...
Breaking Medicine Technology:
(Date:9/25/2017)... , ... September 25, 2017 , ... ... an international competition, were announced on Friday, September 22 during a gala event ... human resources professionals, teams, achievements and HR-related products and suppliers who help to ...
(Date:9/25/2017)... (PRWEB) , ... September 25, 2017 , ... ... further expand its Portable, Continuous, Miniature, and Modular (PCMM) collaboration with Pfizer and ... POD-based Oral Solid Dosage line. The new PODs will provide tablet coating capability ...
(Date:9/25/2017)... ... 2017 , ... Lean Management techniques applied to the laboratory ... for laboratory weighing is designed to help laboratory personnel strengthen lab processes ... on downstream processes. , If a problem is detected, the "First-Defect-Stop" procedure should ...
(Date:9/25/2017)... ... , ... The Asset Tracking and Temperature monitoring system works in conjunction with ... bar code of the product and lot ID then scanning the HPP basket and ... automatically generated and exception alerts sent out to designated individuals. , "In recognizing the ...
(Date:9/25/2017)... Seoul, South Korea (PRWEB) , ... September 25, 2017 , ... ... please those looking for a one-stop shop for the hottest Korean cosmetics and fashion ... natural move for a company that’s already well-known for the great offerings that allow ...
Breaking Medicine News(10 mins):